JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
VINP
Vinci Compass Investments Ltd.
There isn't enough reported data to score VINP yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
VINP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
VINP's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like VINP.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
VINP PE Valuation
VINP has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over VINP on the outlook, with more favorable earnings and revenue expectations.
VINP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect VINP's earnings and profitability to decline, with its revenue holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus VINP down 49%.
VINP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $0.38 | -49% |
| Q3 2024 | $0.59 | -18% |
| Q2 2024 | $0.55 | -35% |
| Q1 2024 | $0.75 | +5.6% |
| Q4 2023 | $0.74 | +4.2% |
| Q3 2023 | $0.72 | +2.9% |
| Q2 2023 | $0.85 | +35% |
| Q1 2023 | $0.71 | +9.2% |
VINP's earnings per share have fallen from their peak: $0.38 over the past year, against $0.85 in mid-2023.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over VINP on profitability, with a higher operating margin.
VINP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $50.1M | +2.1% |
| Q1 2026 | $49.2M | +17% |
| Q4 2025 | $131.8M | +183% |
| Q3 2025 | $63.5M | +188% |
| Q2 2025 | $49M | +86% |
| Q1 2025 | $42M | +115% |
| Q4 2024 | $46.6M | +60% |
| Q3 2024 | $22.1M | +4.6% |
VINP has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 28% | +6.1 points |
| Q1 2026 | 32% | +3.4 points |
| Q4 2025 | 26% | N/A |
| Q3 2025 | -49% | -67 points |
| Q2 2025 | 21% | -17 points |
| Q1 2025 | 29% | -3.7 points |
| Q4 2024 | 18% | -15 points |
| Q3 2024 | 38% | -2.1 points |
VINP's operating margin was 28% last quarter, up 6.1 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
VINP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $10.9M | +6.6% |
| Q1 2026 | -$5M | -449% |
| Q4 2025 | $10.7M | +$11.5M |
| Q3 2025 | $18.3M | +$31.4M |
| Q2 2025 | $10.2M | -63% |
| Q1 2025 | $1.4M | -93% |
| Q4 2024 | -$802.1K | -108% |
| Q3 2024 | -$13.1M | -234% |
VINP has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over VINP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
VINP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.4% | +2.9M shares |
| 1 year | +6.7% | +4.3M shares |
| 3 years | +20% | +11.6M shares |
| 5 years | +32% | +16.7M shares |
| Available history | +23% | +12.8M shares |
VINP has 68M diluted shares, up 6.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $387,401 |
| Q3 2025 | $333,889 |
| Q2 2025 | $1.6M |
| Q1 2025 | $7.2M |
| Q4 2024 | $6.5M |
| Q3 2024 | $4M |
VINP spent $721,290 buying back its own shares over the past year, down 96% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over VINP on leverage, with a lower net debt burden relative to earnings.
VINP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2024 | 3.3x | Elevated |
| Q3 2024 | 2.4x | Moderate |
| Q2 2024 | 2.8x | Moderate |
| Q1 2024 | 2.2x | Moderate |
| Q4 2023 | 2.5x | Moderate |
VINP's net debt is about 1.2 years of its operating earnings (EBITDA), down from 2.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like VINP.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
VINP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.1 | Neutral |
| Stochastic | 8.0 | Oversold |
VINP's weekly RSI is 41 (neutral) and its Stochastic is 8 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
VINP PE vs Financial Services Sector
| Metric | VINP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
VINP has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over VINP on trend strength, trading above more of its moving averages.
VINP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.87 | 11% below |
| 20 week MA | $9.74 | 9.5% below |
| 50 week MA | $10.7 | 18% below |
| 100 week MA | $10.5 | 16% below |
| 200 week MA | $10.3 | 14% below |
VINP is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over VINP on returns for 2026, with the stronger performance.
VINP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $17.1 | $11.2 | -34% |
| 2022 | $11.2 | $8.37 | -25% |
| 2023 | $8.37 | $11.0 | +31% |
| 2024 | $11.0 | $10.0 | -8.5% |
| 2025 | $10.0 | $13.1 | +31% |
| 2026 YTD | $13.1 | $8.81 | -33% |
VINP has finished lower in three of the last five years. It's down 33% so far in 2026.